SCT Plus Immune Therapy in Average Risk AML/MDS

Clinical trial NCT02117297 · COMPLETED

Trial details

NCT number: NCT02117297
Sponsor: New York Medical College
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myelogenous Leukemia Myelodysplastic Syndrome

Start date: 2012-01-12
Primary completion: 2023-03-30
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.